Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
Public ClinicalTrials.gov record NCT06011577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as an Adjunctive Treatment for Major Depressive Disorder (RELIGHT)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 3, randomized, double-blind, placebo-controlled, multicenter trial of REL-1017 in patients with major depressive disorder (MDD).
Study identification
- NCT ID
- NCT06011577
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 27 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 17, 2023 (Actual)
- Primary completion
- Dec 19, 2024 (Actual)
- Completion
- Dec 19, 2024 (Actual)
- Last update posted
- Jul 10, 2026
2023 – 2024
United States locations
- U.S. sites
- 36
- U.S. states
- 16
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Relmada Site | Dothan | Alabama | 36303 | — |
| Relmada Site | Homewood | Alabama | 35209 | — |
| Relmada Site | Anaheim | California | 92805 | — |
| Relmada Site | Lafayette | California | 94549 | — |
| Relmada Site | Newport Beach | California | 92660 | — |
| Relmada Site | Orange | California | 92868 | — |
| Relmada Site | Redlands | California | 92374 | — |
| Relmada Site | Sherman Oaks | California | 91403 | — |
| Relmada Site | Farmington | Connecticut | 06030 | — |
| Relmada Site | Brandon | Florida | 33511 | — |
| Relmada Site | Hialeah | Florida | 33027 | — |
| Relmada Site | Jacksonville | Florida | 32256 | — |
| Relmada Site | Miami | Florida | 33133 | — |
| Relmada Site | Miami | Florida | 33174 | — |
| Relmada Site | Okeechobee | Florida | 34972 | — |
| Relmada Site | Tampa | Florida | 33607 | — |
| Relmada Site | Springfield | Illinois | 62794 | — |
| Relmada Site | Baltimore | Maryland | 21208 | — |
| Relmada Site | Mankato | Minnesota | 56001 | — |
| Relmada Site | Toms River | New Jersey | 08755 | — |
| Relmada Site | Brooklyn | New York | 11235 | — |
| Relmada Site | Cedarhurst | New York | 11516 | — |
| Relmada Site | New York | New York | 10036 | — |
| Relmada Site | Philadelphia | Pennsylvania | 19104 | — |
| Relmada Site | Franklin | Tennessee | 37067 | — |
| Relmada Site | Memphis | Tennessee | 38119 | — |
| Relmada Site | Austin | Texas | 78712 | — |
| Relmada Site | Bellaire | Texas | 77401 | — |
| Relmada Site | Friendswood | Texas | 77546 | — |
| Relmada Site | Houston | Texas | 77030 | — |
| Relmada Site | Wichita Falls | Texas | 76309 | — |
| Relmada Site | Clinton | Utah | 84015 | — |
| Relmada Site | Draper | Utah | 84020 | — |
| Relmada Site | Rutland | Vermont | 05701 | — |
| Relmada Site | Charlottesville | Virginia | 22903 | — |
| Relmada Site | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06011577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 10, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06011577 live on ClinicalTrials.gov.